TON hamyonining Telegram mijoziga integratsiyasi
WebApp-botlari tufayli @wallet xizmati hamyonni Telegram mijozlari investitsiyalariga integratsiyalashni amalga oshirdi.
Endi siz Toncoin kriptovalyutasini foydalanuvchilarga bevosita messenjerdan o‘tkazishingiz mumkin. Uzoq hamyon manzillarisiz, komissiyalarsiz va tranzaksiyani tasdiqlashni kutmasdan.
Avvalroq @tginfoyozganidek, ehtimol, butun veb-bot platformasi TON Coin'ning Telegram bilan integratsiyalashuvi uchun maxsus yaratilgan.
Hamyonni integratsiyalash: t.me/wallet?attach=wallet
TonCoin haqida batafsil: @toncoin_uz
#ton#wallet#kriptovalyuta
💚@TGraphUz | YouTube
¡Tu crecimiento profesional no se detiene! 📈
Estamos diseñando un espacio donde la teoría y la práctica se encuentran para fortalecer tus competencias clínicas. Guías descargables, sesiones en vivo y certificación mensual son solo el comienzo.
Mantente conectado. Lo que viene superará tus expectativas ✨
🌐 Visítanos: vetplusacademy.com
📲 WhatsApp: +58 414 5300397
#VetPlus#Vets#MedVet#EstudiantesVeterinaria#VetPlusUltra
NEWS
🔻𝗪𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 𝗱𝗿𝘂𝗴𝘀 𝗳𝗼𝗿 𝗰𝗮𝘁𝘀? 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝘀 𝗶𝗻 𝗰𝗮𝘁𝘀
#Okava_Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new #GLP_1 clinical weight loss study for cats.
#MEOW_1, as the study is called, will look to use #OKV_119, a miniature implant, in cats which will deliver the GLP-1, continuously for up to six months.
According to #Okava, MEOW-1 is the first-ever weight loss trial using this approach on household pets.
Klotsman said the goal would be to file for #FDA approval for the product between 2027 and 2028, and the target is for the product to cost owners an out-of-pocket payment of around $100 per month.
Read the full story 👇
https://abcnews.go.com/GMA/Wellness/weight-loss-drugs-cats-company-launches-clinical-trial/story?id=128054236
#feline#cats#pets#petobesity#petcare#okavapharmaceuticals#sanfrancisco#vets#petowners#veterinarians#dvm